UBS Remains Sidelined as Swift Transportation's (SWFT) New Outlook Underlines Weak Freight Environment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Pre-Open Stock Movers 10/27: (TRIV) (UQM) (BABA) Higher; (RRTS) (RCII) (MRVL) Lower (more...)
October 27, 2015 9:31 AM EDTTriVascular Technologies, Inc. (Nasdaq: TRIV) 50.8% HIGHER; Endologix (NASDAQ: ELGX) and TriVascular Technologies, Inc. (Nasdaq: TRIV) announced today that they have entered into a definitive merger agreement under which Endologix and TriVascular will combine in a stock and cash transaction. The transaction is valued at $9.10 per TriVascular share, or a total of approximately $211 million, based on Endologix's closing stock price of $13.81 per share on October 23, 2015.
Roadrunner Transportation (NYSE:... More
After-Hours Movers 10/26: (TRIV) (IDTI) (EW) Higher; (RCII) (MRVL) (MSTR) Lower (more...)
October 26, 2015 5:51 PM EDTTriVascular Technologies, Inc. (Nasdaq: TRIV) 50.8% HIGHER; Endologix (NASDAQ: ELGX) and TriVascular Technologies, Inc. (Nasdaq: TRIV) announced today that they have entered into a definitive merger agreement under which Endologix and TriVascular will combine in a stock and cash transaction. The transaction is valued at $9.10 per TriVascular share, or a total of approximately $211 million, based on Endologix's closing stock price of $13.81 per share on October 23, 2015.
Swift Transportation (SWFT) Misses Q3 EPS by 1c, Offers Q4 Guidance
October 26, 2015 4:03 PM EDTSwift Transportation (NYSE: SWFT) reported Q3 EPS of $0.31, $0.01 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $1.07 billion versus the consensus estimate of $1.08 billion.
The company sees Q4 EPS of $0.47-$0.51 vs the consensus of $0.51.
For earnings history and... More
Trading Radar for 10/26: Crane (CR), Xerox (XRX), W.R. Berkley (WRB), Taubman Centers (TCO) Report
October 23, 2015 3:03 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
Bank Of Hawaii Corp. (NYSE: BOH) - consensus EPS $0.95
Changyou.com (Nasdaq: CYOU) - consensus EPS $0.72
Check Point Software Technology (NYSE: (Nasdaq: ) - consensus EPS $0.98
JAKKS Pacific (Nasdaq: JAKK) - consensus EPS $1.09
Lab Corp. (NYSE: LH) - consensus EPS $2.07
LendingTree (Nasdaq: TREE) -... More
